Non-covalent BTK inhibitor pirtobrutinib shows promise as frontline therapy for CLL/SLL
Non-covalent BTK inhibitor pirtobrutinib shows promise as frontline therapy for CLL/SLL
Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive frontline responses
Empowering cancer care in Africa
Pimicotinib in TGCT demonstrates durable responses and sustained functional improvement
Latest in bladder cancer from the second half of 2025
IPSO guidelines on minimally invasive surgery in paediatric solid tumours
Choosing Wisely: Managing resectable colorectal liver metastases
Cancer control in India - Role of cancer registries
Optimal management of gastric cancers
Precision approaches to treating HPB cancers
Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers
Panel Discussion: Case based discussions muscle invasive bladder cancer